Efficacy, Safety, and Immunogenicity of SDZ-ADL, an Adalimumab Biosimilar, in Biologic-Naïve and Switched Patients with Immune-Mediated Inflammatory Diseases: A Literature Review
Title:
Efficacy, Safety, and Immunogenicity of SDZ-ADL, an Adalimumab Biosimilar, in Biologic-Naïve and Switched Patients with Immune-Mediated Inflammatory Diseases: A Literature Review
Author:
Wiland, Piotr Both, Charlotte Gaylis, Norman B. Cohen, Russell D. Halfvarson, Jonas Lemke, Lena von Richter, Oliver Blauvelt, Andrew